Ravikumar Sitapara

676 total citations
18 papers, 489 citations indexed

About

Ravikumar Sitapara is a scholar working on Pulmonary and Respiratory Medicine, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Ravikumar Sitapara has authored 18 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Clinical Biochemistry and 6 papers in Molecular Biology. Recurrent topics in Ravikumar Sitapara's work include Advanced Glycation End Products research (8 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Neuroscience of respiration and sleep (4 papers). Ravikumar Sitapara is often cited by papers focused on Advanced Glycation End Products research (8 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Neuroscience of respiration and sleep (4 papers). Ravikumar Sitapara collaborates with scholars based in United States, Germany and United Kingdom. Ravikumar Sitapara's co-authors include Lin L. Mantell, Lokesh Sharma, Vivek Patel, Haichao Wang, Charles R. Ashby, Huan Yang, Kevin J. Tracey, Sangeeta S. Chavan, Mohammad Javdan and Mao Wang and has published in prestigious journals such as International Journal of Molecular Sciences, American Journal Of Pathology and European Respiratory Journal.

In The Last Decade

Ravikumar Sitapara

16 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravikumar Sitapara United States 12 166 164 147 125 68 18 489
Saskia N. van der Crabben Netherlands 8 56 0.3× 87 0.5× 75 0.5× 149 1.2× 12 0.2× 12 609
Zhenggang Luan China 10 49 0.3× 147 0.9× 82 0.6× 106 0.8× 24 0.4× 15 402
Anjali Kumar United States 3 25 0.2× 190 1.2× 174 1.2× 125 1.0× 31 0.5× 6 347
Richard D. Collage United States 9 45 0.3× 37 0.2× 44 0.3× 110 0.9× 16 0.2× 10 423
John R. Janczy United States 6 98 0.6× 28 0.2× 397 2.7× 817 6.5× 66 1.0× 6 1.1k
Erica Fan United States 10 151 0.9× 21 0.1× 348 2.4× 376 3.0× 26 0.4× 14 715
Iriana Colorado United States 9 81 0.5× 9 0.1× 107 0.7× 100 0.8× 43 0.6× 13 465
Peter Ruef Germany 13 225 1.4× 14 0.1× 118 0.8× 99 0.8× 11 0.2× 50 605

Countries citing papers authored by Ravikumar Sitapara

Since Specialization
Citations

This map shows the geographic impact of Ravikumar Sitapara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravikumar Sitapara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravikumar Sitapara more than expected).

Fields of papers citing papers by Ravikumar Sitapara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravikumar Sitapara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravikumar Sitapara. The network helps show where Ravikumar Sitapara may publish in the future.

Co-authorship network of co-authors of Ravikumar Sitapara

This figure shows the co-authorship network connecting the top 25 collaborators of Ravikumar Sitapara. A scholar is included among the top collaborators of Ravikumar Sitapara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravikumar Sitapara. Ravikumar Sitapara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
3.
Pullamsetti, Soni Savai, Ravikumar Sitapara, Robin Osterhout, et al.. (2023). Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 24(16). 12653–12653. 11 indexed citations
4.
Galkin, Anna, Ravikumar Sitapara, Bryan Clemons, et al.. (2022). Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension. European Respiratory Journal. 60(6). 2102356–2102356. 49 indexed citations
5.
8.
Sitapara, Ravikumar, TuKiet T. Lam, Aneta Gandjeva, Rubin M. Tuder, & Lawrence S. Zisman. (2021). Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension. Pulmonary Circulation. 11(3). 1–15. 1 indexed citations
9.
Sitapara, Ravikumar, Alex Gauthier, Sergio Iván Valdés‐Ferrer, et al.. (2020). The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Molecular Medicine. 26(1). 63–63. 34 indexed citations
10.
Sitapara, Ravikumar, et al.. (2020). GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Molecular Medicine. 26(1). 98–98. 11 indexed citations
11.
Patel, Vivek, Michael Graham Espey, Ravikumar Sitapara, et al.. (2016). Ascorbic Acid Attenuates Hyperoxia-Compromised Host Defense against Pulmonary Bacterial Infection. American Journal of Respiratory Cell and Molecular Biology. 55(4). 511–520. 17 indexed citations
12.
Wang, Mao, Daniel J. Antoine, Ravikumar Sitapara, et al.. (2014). The Compromise of Macrophage Functions by Hyperoxia Is Attenuated by Ethacrynic Acid via Inhibition of NF-κB–Mediated Release of High-Mobility Group Box-1. American Journal of Respiratory Cell and Molecular Biology. 52(2). 171–182. 25 indexed citations
13.
Sharma, Lokesh, Wenjun Wu, Jiao Wu, et al.. (2014). Assessment of Phagocytic Activity of Cultured Macrophages Using Fluorescence Microscopy and Flow Cytometry. Methods in molecular biology. 1172. 137–145. 28 indexed citations
14.
Javdan, Mohammad, Daniel J. Antoine, Ravikumar Sitapara, et al.. (2014). Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury. Redox Biology. 2. 314–322. 99 indexed citations
15.
Sharma, Lokesh, Jiao Wu, Vivek Patel, et al.. (2013). Partially-desulfated heparin improves survival inPseudomonaspneumonia by enhancing bacterial clearance and ameliorating lung injury. Journal of Immunotoxicology. 11(3). 260–267. 23 indexed citations
16.
Ashby, Charles R., Ryan Pekson, Ravikumar Sitapara, et al.. (2013). N,N-Dimethylacetamide Regulates the Proinflammatory Response Associated with Endotoxin and Prevents Preterm Birth. American Journal Of Pathology. 183(2). 422–430. 25 indexed citations
17.
Patel, Vivek, Ravikumar Sitapara, Lokesh Sharma, et al.. (2013). High Mobility Group Box–1 Mediates Hyperoxia-Induced Impairment of Pseudomonas aeruginosa Clearance and Inflammatory Lung Injury in Mice. American Journal of Respiratory Cell and Molecular Biology. 48(3). 280–287. 67 indexed citations
18.
Weiss, Daniel J., Ravikumar Sitapara, L R Whittaker, et al.. (2012). Inhibition of High-Mobility Group Box 1 Protein (HMGB1) Enhances Bacterial Clearance and Protects against Pseudomonas Aeruginosa Pneumonia in Cystic Fibrosis. Molecular Medicine. 18(3). 477–485. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026